Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate, ClinicoEconomics and Outcomes Research, July 2017, Dove Medical Press,
DOI: 10.2147/ceor.s141610.
You can read the full text:
Contributors
The following have contributed to this page
